97 related articles for article (PubMed ID: 7024948)
1. [Biological properties of fibrinogen degradation products by thrombin].
Buczko W
Pol Tyg Lek; 1981 Jun; 36(23):855-6. PubMed ID: 7024948
[No Abstract] [Full Text] [Related]
2. [Endogenous peptides--physiological regulators of coagulative conversion of fibrinogen].
Byshevskiĭ ASh; Chiriat'ev EA; Leonova OP
Gematol Transfuziol; 1991 Apr; 36(4):28-31. PubMed ID: 2065963
[No Abstract] [Full Text] [Related]
3. [Thrombin-fibrinogen interaction: release of fibrinopeptides and the effects of ATP].
Gurrieri MA
Medicina (Firenze); 1990; 10(1):51-2. PubMed ID: 2381284
[TBL] [Abstract][Full Text] [Related]
4. The release of small amounts of fibrinopeptide-B (FPB) is of critical importance for the thrombin clotting time.
Holm B; Kierulf P; Godal HC
Thromb Res; 1986 May; 42(4):517-26. PubMed ID: 3715815
[TBL] [Abstract][Full Text] [Related]
5. Effects of extravascular clotting on fibrinopeptide A levels in blood.
Wilner GD; Chatpar P; Te A; Horowitz J
J Lab Clin Med; 1978 Feb; 91(2):205-13. PubMed ID: 621423
[No Abstract] [Full Text] [Related]
6. Chemotaxis for human monocytes by fibrinogen-derived peptides.
Richardson DL; Pepper DS; Kay AB
Br J Haematol; 1976 Apr; 32(4):507-13. PubMed ID: 1259932
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation.
Wojtecka-Lukasik E; Maśliński S
J Physiol Pharmacol; 1992 Jun; 43(2):173-81. PubMed ID: 1382726
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for measurement of circulating fibrinogen derivatives.
Wilner GD
Prog Hemost Thromb; 1978; 4():211-48. PubMed ID: 152445
[TBL] [Abstract][Full Text] [Related]
9. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
Del Principe D; Strappini PM; Del Vecchio S; Menichelli A; Biancini G; Cosmi EV; Bastianon V; D'Arcangelo C
Thromb Haemost; 1981 Oct; 46(3):581-3. PubMed ID: 7031980
[TBL] [Abstract][Full Text] [Related]
10. Role of fibrinopeptide B in early atherosclerotic lesion formation.
Singh TM; Kadowaki MH; Glagov S; Zarins CK
Am J Surg; 1990 Aug; 160(2):156-9. PubMed ID: 2382767
[TBL] [Abstract][Full Text] [Related]
11. Congenital dysfibrinogenemia.
Rupp C; Beck EA
Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
[No Abstract] [Full Text] [Related]
12. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
Barczak-Osińska J; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
[TBL] [Abstract][Full Text] [Related]
13. Biological properties of fibrinogen derivatives relevant to the function of cardiovascular system and immuno-inflammatory reaction.
Kopec M
New Istanbul Contrib Clin Sci; 1977 Sep; 12(1):43-9. PubMed ID: 565049
[No Abstract] [Full Text] [Related]
14. Structure and function of fibrinogen.
Doolittle RF
Horiz Biochem Biophys; 1977; 3():164-91. PubMed ID: 328365
[No Abstract] [Full Text] [Related]
15. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human fibrinopeptides by high-performance liquid chromatography.
Kehl M; Lottspeich F; Henschen A
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
[TBL] [Abstract][Full Text] [Related]
17. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
[TBL] [Abstract][Full Text] [Related]
18. Growth factors for human fibroblasts in the solute remaining after clot formation.
Gray AJ; Reeves JT; Harrison NK; Winlove P; Laurent GJ
J Cell Sci; 1990 Jun; 96 ( Pt 2)():271-4. PubMed ID: 2211868
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of canine fibrinogen: in vitro synthesis of A alpha, B beta and gamma precursor chains.
Yu S; Redman CM; Goldstein J; Blombäck B
Biochem Biophys Res Commun; 1980 Oct; 96(3):1032-8. PubMed ID: 7437057
[No Abstract] [Full Text] [Related]
20. [Fibrinopeptide].
Shibusawa K
Kango; 1981 Apr; 33(4):82. PubMed ID: 6911340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
